Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Depreciation & Amortization (CF) (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $16802.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 44.74% to $16802.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $72167.0, a 24.78% decrease, with the full-year FY2024 number at $95368.0, up 28.58% from a year prior.
  • Depreciation & Amortization (CF) was $16802.0 for Q3 2025 at GeoVax Labs, roughly flat from $16803.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $30408.0 in Q3 2024 to a low of $4517.0 in Q1 2021.
  • A 5-year average of $16572.0 and a median of $16921.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): soared 354.43% in 2021, then plummeted 44.74% in 2025.
  • GeoVax Labs' Depreciation & Amortization (CF) stood at $11715.0 in 2021, then increased by 20.11% to $14071.0 in 2022, then surged by 57.86% to $22213.0 in 2023, then dropped by 2.58% to $21641.0 in 2024, then decreased by 22.36% to $16802.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Depreciation & Amortization (CF) are $16802.0 (Q3 2025), $16803.0 (Q2 2025), and $16921.0 (Q1 2025).